The US Food and Drug Administration's recent changes in its homeopathic industry oversight react to growth the agency didn't anticipate when it adopted a policy guide three decades ago that set parameters for manufacturing and marketing the products.
"The agency has been looking at this over time
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?